The identification of mutations in components of the TGFβ pathway, such as TGFBR2, SMAD2, SMAD3, SMAD4 and ENG, demonstrate the tumour suppressor role this pathway can play [130,131,132,133]. Here, TGFB1 is linked to neoplasm.